Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Combination product packaging

The healthcare industry is headed to drug combination products containing two or more regulated components that are physically, chemically, or otherwise combined as a single entity.

Pw 12044 Mdm

Insights here are courtesy of Hal Miller of consultancy PACE Solutions, LLC, based on his presentation at MD&M West in January.

• Combination product examples could be a drug-eluting stent, an antibiotic bone cement, or orthopedic implants with genetically engineered human protein. The differences between medical devices are that a device package protects the product, allows for sterilization and maintains sterility that until use. Drugs and biologic products are focused on the safety and efficacy of the product until its expiration date. Also, drugs are very regulated, while devices have guidelines. Combination products can be shipped in the same distribution system.

• Medical device packaging materials must be nontoxic and biocompatible, with porous materials providing adequate microbial barrier. Sterilization should not affect materials or packages. Use aging or stability studies to demonstrate there are sufficient physical properties to protect the device from damage and maintain sterile package integrity until its expiry date.

• For drug packaging, refer to the FDA’s Guideline for container closure systems for packaging human drugs and biologics, published in May, 1999. Drug packagers should be concerned with the proposed FDA guideline for container and closure systems, and that components are suitable for use. Batch-to-batch uniformity of packaging components is also important.. Chapter 661 in USP should be your friend when it comes to developing packaging for drugs.

• Sterilization considerations: Aseptic processing is expensive, while terminal sterilization is preferred. Consider nonstandard sterilization cycles that will not harm or affect the product (large molecule proteins, live cells, and drug chemistry), as well as low-dose irradiation and low-temperature/low-concentration EtO. [HCP]

Is your palletizing solution leaving money on the floor?
Discover which palletizing technology—robotic, conventional, or hybrid—will maximize your packaging line efficiency while minimizing long-term costs in this comprehensive analysis.
Read More
Is your palletizing solution leaving money on the floor?
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics